This is the critical quote, is it not?
“We are encouraged by the PFS and anticipated primary OS clinical data to commence three new HER-Vaxx trials..."
Sounds like the overall survival rate will be pleasantly surprising.
I would have like more comment from Lesley explaining the significance of the raw numbers presented today. As a layman, I struggle to interpret bio results.
Market action in the past two days suggests knowledge was afoot that Imugene was about to announce ... something. One suspects it might be a case of buy the rumor and that today could be sell the news. Let's see.
OOO
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-48
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.5¢ | $954.9K | 16.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 847774 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 1472351 | 8 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.000 ( 1.93 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.7¢ | 5.5¢ | 5009307 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| IMU (ASX) Chart |
